Trial Profile
Effect of LM11A-31 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 May 2016
Price :
$35
*
At a glance
- Drugs LM 11A-31 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 05 May 2016 According to PharmatrophiX company website, this study was completed during 2013-2014 and this study was supported by peer-reviewed funding from the ADDF, peer-reviewed funding by the Alzheimer's Association's Part-the-Cloud-Program, and by private investors.
- 05 May 2016 New trial record